Portal under development — full launch coming soon

Beta · 2026
India's AI-Enabled Site Management Organisation

One Network.
Every Trial.
Faster.

SiteInsight Research connects global sponsors and CROs to India's most trusted clinical trial infrastructure — 120+ pre-qualified sites, 300+ GCP-certified investigators, AI feasibility in 24 hours.

24hAI Feasibility
120+Qualified Sites
300+PIs & CRCs
6–8wActivation
How it works
01
Protocol Synopsis
Sponsor sends under CDA
AI Analysis · 60 sec
02
SiteInsight AI Engine
120+ sites · 300+ PIs · 18 TAs
Live
Ranked output · 24 hrs
03
Ranked Site Shortlist
Scores · PI interest · Patient pool
Same day
04
One Contract · All Sites
PIs · CRCs · EC submissions
05
Site Activated
Recruitment · EDC · Close-out
6–8 wks
Full portal launching soon
ProClin Research Pvt. Ltd. Delhi NCR, India Phase I – IV 22 Cities 18 Therapeutic Areas siteinsight.in
ICH-GCP E6(R3) NDCT Rules 2019 21 CFR Part 11 GDPR Aligned DPDP Act 2023 CDSCO Registered
Who We Are

India's most complete clinical trial site network.

SiteInsight Research is the dedicated Site Management Organisation of ProClin Research — one of India's most trusted CROs. We exist to solve the biggest cost-driver in global clinical trials: the time and effort to identify, activate and manage research sites in India.

Where a sponsor might spend weeks chasing individual hospitals and investigators, SiteInsight provides a single, accountable partner — with a pre-qualified, compliance-ready network already in place.

Talk to our team →
  • AI-Powered FeasibilityProtocol synopsis to ranked site shortlist in 24 hours. India's first and only AI feasibility engine for SMOs.
  • 120+ Pre-Qualified SitesHospitals, polyclinics, standalone research centres and NABL labs — CDSCO EC-registered, across 22 Indian cities.
  • 300+ GCP-Certified PIs & CRCsInvestigators mapped by specialty and enrolment record. Coordinators deployed and managed by SiteInsight at every site.
  • One Contract. Every Site.Single SMO agreement replaces dozens of individual negotiations. One invoice, one point of accountability.
  • 6–8 Weeks Site ActivationHalf the 12–16 week industry average. Pre-qualified sites and template agreements skip months of contracting.
24hAI Feasibility

Synopsis to shortlist, same day

120+Research Sites

Hospitals, polyclinics & NABL labs

300+PIs & CRCs

GCP-certified, deployed & managed

18Therapeutic Areas

Phase I–IV capability across all

22Cities

Metro & Tier-2 India covered

Why Every Day Matters

A single day of delay costs a sponsor $8 million.
It costs a patient something priceless.

Trial delays don't just appear on a P&L — they appear at a patient's bedside. SiteInsight exists to close that gap from both sides.

$8M
The Sponsor Side
$8M per day lost

For a blockbuster drug in late-stage trials, a single day of delay costs roughly $8 million in lost patent life, deferred revenue and wasted operational spend.

Patent life eroded −1 day irreplaceable
Site idle cost Burns with zero output
Competitor advantage Market window narrows
80% of trials delayed Industry avg: +11 weeks

SiteInsight's AI feasibility response in 24 hours vs the industry's 5–7 day average saves sponsors the first week before a single site is even contracted.

365
The Patient Side
1 Day can change everything

For a patient with a rare cancer, advanced neurological condition or drug-resistant infection — access to a trial isn't an option. It's often the only option. Every week of delay is a week without hope of a better therapy.

Trial not available nearby Patient gives up
Enrolment delayed 3 months Disease progresses
Site not GCP-ready Trial bypasses region
85% of Indian patients Never access a trial

SiteInsight's 120+ network sites across 22 Indian cities bring clinical trial access to patients in Tier-2 cities who would otherwise never be offered a trial slot.

"SiteInsight's mandate is to make every day count — for the sponsor losing millions to delay, for the investigator whose site needs to be ready, and for the patient who cannot afford to wait."

SiteInsight Research · ProClin Research Leadership
Our Services

The complete SMO service stack

Everything a sponsor needs to run a clinical trial in India — from site identification to study close-out — under one accountable roof.

01

Research Site Network

120+ pre-qualified sites across metro and Tier-2 India. CDSCO-registered Ethics Committees at every site. Full compliance documentation maintained.

02

Principal Investigator Network

300+ GCP-certified PIs mapped by specialty, phase experience and enrolment track record. Interest confirmed before feasibility is submitted.

03

CRC Deployment & Management

Protocol-briefed coordinators placed and managed by SiteInsight at each site. Source docs, EDC entry, visit scheduling — from day one.

04

AI-Powered Feasibility

Protocol synopsis to ranked site shortlist with patient pool estimates within 24 hours. India's fastest feasibility turnaround.

05

Regulatory & EC Submissions

End-to-end EC dossier preparation, CDSCO coordination, regional-language ICF translations and audit-ready document management.

06

Patient Recruitment & Retention

Community outreach, PHC referral networks and WhatsApp-based retention programs built for Indian patient populations.

07

Medical Writing Support

AI-assisted ICF drafts, cover letters, SOPs and EC dossiers — reviewed by our regulatory team. Regional-language translations included.

08

GCP Training & Site Development

Modular GCP certification for new PIs and CRCs. Protocol-specific training, audit-readiness workshops and inspection simulation.

Site Registry Portal

Search India's Clinical Trial Network

A searchable registry of all 120+ qualified sites, filterable by therapeutic area, phase and region — with direct feasibility requests.

SiteInsight Site Registry

Under Development
Coming Soon

The full interactive site registry — with real-time search, TA filtering, PI profiles and AI feasibility — is currently in development. Full launch Q3 2026.

Site Database

Complete

120+ sites qualified, documented and ready for listing

AI Feasibility Engine

In Progress

AI matching and ranking system — 75% complete

Sponsor Portal

Q3 2026

Full sponsor dashboard, shortlisting and request management

Get notified when the portal launches:

Compliance

Built for Indian, US and international regulation

Every site, document and workflow governed by a quality framework spanning three jurisdictions.

Jurisdiction · India

Indian Framework

  • NDCT Rules, 2019Trial conduct, compensation & DCGI approvals
  • CDSCO RegistrationRegistered ECs at all network sites
  • ICMR Guidelines, 2017Ethical conduct for human research
  • DPDP Act, 2023Participant data protection compliance
Jurisdiction · United States

US FDA Framework

  • 21 CFR Part 11E-records, e-signatures & audit trails
  • 21 CFR Parts 50 & 56Informed consent & IRB standards
  • HIPAA AlignmentPHI handling for US-sponsor studies
  • BIMO Inspection ReadinessAudit-ready files from activation
Jurisdiction · EU & Global

International Standards

  • GDPRLawful basis & SCCs for EU sponsors
  • ICH-GCP E6(R3)Operating baseline across all sites
  • Declaration of HelsinkiEthical principles for human research
  • CDA / DPA ContractsConfidentiality on every engagement
Validated Systems

Part 11-aligned e-signatures, immutable audit trails, role-based access controls.

Data Encryption

Encrypted in transit and at rest. Least-privilege access with periodic review.

Consent Management

Version-controlled ICFs with regional translations and re-consent tracking.

eTMF-Ready Files

Essential document management, inspection logs and CAPA at each site.

Join the Network

PIs and sites — bring global trials to your door

SiteInsight matches your specialty to sponsor pipelines and handles contracts, compliance and coordination.

For doctors ready to lead research

  • Matched protocols — studies aligned to your specialty and patient pool, not cold outreach.
  • CRC support included — trained coordinators deployed so research never competes with your clinic.
  • GCP training & mentoring — certification support and first-trial handholding for new investigators.
  • Transparent budgets — standardised agreements with clear, timely payments.

Apply to the PI Network

Reviewed by our medical affairs team within 5 business days.

Data handled per DPDP Act 2023 and GDPR-aligned policies. Never shared without consent.

For hospitals, labs & research centres

  • Sponsor visibility — a verified profile seen by pharma sponsors and CROs planning India studies.
  • Startup done for you — EC registration support, SOPs, staff training and inspection readiness.
  • Labs welcome — NABL labs and imaging centres join as service providers.
  • No exclusivity lock-in — keep independent research relationships alongside network studies.

Register your Facility

Our qualification team responds within 5 business days.

Data handled per DPDP Act 2023 and GDPR-aligned policies.
Get Started

Planning a trial in India?

Send us a protocol synopsis — even a rough one. Our team returns a feasibility assessment, qualified site shortlist and enrolment projection within 24 hours, under full confidentiality.

Request Feasibility

Response within 1 business day · CDA available on request